https://www.selleckchem.com/pr....oducts/litronesib.ht
Inhibition of PKA by H89 abolished the effects of nintedanib on SOX-9 and Col II expression. Taken together, nintedanib presented protective effects on TNF-α-induced oxidative stress, inflammation, and ECM damage in CHON-001 chondrocytes. Mechanically, the effect of nintedanib is associated with the PKA/CREB pathway. These data imply that the anti-fibrotic agent nintedanib may have a potential therapeutic application for osteoarthritis.Knowledge of uncertainty is valuable mainly in correctly appraising measured effects. In lower limb
Like
Comment
Share
